I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase II study of nivolumab and salvage nivolumab/ipilimuma..:
Atkins, Michael B
;
Jegede, Opeyemi A
;
Haas, Naomi B
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 3 - p. e004780 , 2023
Link:
https://doi.org/10.1136/jitc-2022-004780
RT Journal T1
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
UL https://suche.suub.uni-bremen.de/peid=cr-10.1136_jitc-2022-004780&Exemplar=1&LAN=DE A1 Atkins, Michael B A1 Jegede, Opeyemi A A1 Haas, Naomi B A1 McDermott, David F A1 Bilen, Mehmet A A1 Stein, Mark A1 Sosman, Jeffrey A A1 Alter, Robert A1 Plimack, Elizabeth R A1 Ornstein, Moshe C A1 Hurwitz, Michael A1 Peace, David J A1 Signoretti, Sabina A1 Denize, Thomas A1 Cimadamore, Alessia A1 Wu, Catherine J A1 Braun, David A1 Einstein, David A1 Catalano, Paul J A1 Hammers, Hans PB BMJ YR 2023 SN 2051-1426 JF Journal for ImmunoTherapy of Cancer VO 11 IS 3 SP e004780 LK http://dx.doi.org/https://doi.org/10.1136/jitc-2022-004780 DO https://doi.org/10.1136/jitc-2022-004780 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)